beta

AGN

Allergan plc

Agn

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Allergan PLC is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and OTC pharmaceutical products.

Market Cap: 62.2 Billion

Primary Exchange: New York Stock Exchange

Website: http://www.allergan.com

Shares Outstanding: 333 Million

Float: 330 Million

Dividend: 2.8 (1.5%)

Beta: 1.234322

Sector: Healthcare

Industry: Drug Manufacturers

Short Interest (Jan 12, 2018): 11 Million

Ethical Flags

Animal testing

Longest drawdown: 1575 trading days

From: 2015-07-28 To: 2019-10-11

Lowest Point:

FDA Approves Amgen And Allergan's KANJINTI(TM) (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)

via: PR Newswire at 2019-06-13 15:13:00:000

THOUSAND OAKS, Calif. , June 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI (trastuzumab-anns) for all approved indications of the reference product, Herceptin … read more...

Billionaires Love 50 Stocks And 31 Of Those Pay Dividends

via: SeekingAlpha at 2019-06-13 10:41:44:000

James Brumley says in Kiplinger Investing : "Rich people often get perpetually richer for a reason, so it could be worthwhile to study what billionaires and high-asset hedge funds are plowing their long-term capital into." As any collection of stocks is more clearly understood when subj… read more...

Akero Therapeutics Readies $75 Million IPO

via: SeekingAlpha at 2019-06-13 09:11:26:000

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...

Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q1 2019 Update

via: SeekingAlpha at 2019-06-13 04:50:49:000

This article is part of a series that provides an ongoing analysis of the changes made to Wallace Weitzs 13F portfolio on a quarterly basis. It is based on Weitzs regulatory 13F Form filed on 05/14/2019. Please visit our Tracking Wallace Weitzs Weitz Investment Manag… read more...

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

FDA Ad Com tomorrow on utility of higher-dose opioids

via: SeekingAlpha at 2019-06-10 13:06:51:000

The FDA's Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee will jointly mee t tomorrow and Wednesday, June 11 & 12, to seek public input on the clinical utility and safety concerns associated with higher range opioid an… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2019-08-12 2019-09-13 2019-08-13 2019-07-19 0.74 No Change QoQ
2019-05-13 2019-06-14 2019-05-14 2019-05-03 0.74 No Change QoQ
2019-02-14 2019-03-15 2019-02-15 2019-01-25 0.74 Increase
2018-11-12 2018-12-14 2018-11-13 2018-10-26 0.72 No Change QoQ
2018-08-16 2018-09-17 2018-08-17 2018-07-30 0.72 No Change QoQ
2018-05-17 2018-06-15 2018-05-18 2018-05-03 0.72 No Change QoQ
2018-02-27 2018-03-28 2018-02-28 2018-02-09 0.72 Increase
2017-11-16 2017-12-15 2017-11-17 2017-10-27 0.7 No Change QoQ
2017-08-16 2017-09-15 2017-08-18 2017-08-02 0.7 No Change QoQ
2017-05-16 2017-06-15 2017-05-18 2017-05-05 0.7 No Change QoQ
2017-02-24 2017-03-28 2017-02-28 2016-11-02 0.7 Initiation
2015-02-05 2015-03-20 2015-02-09 2015-02-04 0.05 No Change QoQ
2014-11-18 2014-12-11 2014-11-20 2014-10-27 0.05 No Change QoQ
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud